🏠

Saxenda®
RX Navigator

Interactive safety profile visualization for Saxenda® (liraglutide), based on the official Summary of Product Characteristics.

Patient Data

Age (years)

BMI (kg/m²)

Pediatric Weight (kg)

Duration of Use (weeks)

Creatinine Clearance (mL/min)

Clinical Situation and Conditions

Allergy to Saxenda Pregnancy Breast-feeding Prediabetes / T2DM Hypertension Dyslipidaemia Obstructive Sleep Apnoea CHF NYHA Class IV Severe Renal Impairment (CrCl < 30) End-Stage Renal Disease Severe Hepatic Impairment Mild/Moderate Hepatic Impairment Inflammatory Bowel Disease (IBD) Diabetic Gastroparesis History of Pancreatitis History of Gallstones / Cholecystitis Thyroid Disease Prader-Willi Syndrome No effect: Adults (< 5% weight loss at 12 wks on 3.0 mg) No effect: Children 12+ (< 4% BMI reduction at 12 wks)

Concomitant Medications

Other weight management products Other GLP-1 receptor agonists Insulin Sulfonylureas Warfarin or other coumarins Oral contraceptives Paracetamol Atorvastatin Digoxin Lisinopril Griseofulvin

*according to the official Summary of Product Characteristics

Risk Factors

Key Information from SmPC:

This tool is intended for informational purposes only. It is not a medical device and is not designed for diagnosis, treatment prescription, or clinical decision-making. The information provided does not replace a thorough review of the official prescribing information for the medicinal product and should not be used as a substitute for the professional judgment of a physician or pharmacist.

Saxenda®RX Navigator

Risk Factors

Key Information from SmPC:

Saxenda®
RX Navigator